Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion type Assertion NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_head.
- NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion description "[Amplification of the CBFbeta/MYH11 fusion transcript by a qualitative reverse transcription-polymerase chain reaction (RT-PCR) has been used to detect minimal residual disease (MRD) and assess the risk for disease relapse in inv(16)(p13q22) acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_provenance.
- NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion evidence source_evidence_literature NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_provenance.
- NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion SIO_000772 11455976 NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_provenance.
- NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion wasDerivedFrom befree-20140225 NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_provenance.
- NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_assertion wasGeneratedBy ECO_0000203 NP535310.RAMYM9mhXcAOnNmTzbVNuCw4Za0FqULec5nCEseUrC7wg130_provenance.